How can I differentiate impetigo from an acid chemical burn in a skin lesion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiating Impetigo from Acid Chemical Burns

Impetigo presents with honey-colored crusts on erythematous bases that evolve from vesicles/pustules over 4-6 days, while acid burns show immediate tissue destruction with well-demarcated necrosis, coagulation, and eschar formation at the contact site without the characteristic progression through vesicular stages.

Key Clinical Features That Distinguish These Conditions

Impetigo Characteristics

  • Lesion evolution: Begins as erythematous papules that rapidly progress to vesicles, then pustules, and finally form thick honey-colored crusts over 4-6 days 1
  • Distribution pattern: Typically occurs on exposed areas, most frequently the face and extremities, often at sites of minor trauma or insect bites 1
  • Bullous variant: When caused by toxin-producing S. aureus, presents with fragile, thin-roofed vesicopustules that rupture easily, leaving denuded areas with collarette of scale 1
  • Associated findings: Regional lymphadenitis may be present, but systemic symptoms (fever, malaise) are usually absent 1
  • Contagious nature: Highly transmissible through direct contact, with multiple lesions often appearing in clusters 2

Acid Chemical Burn Characteristics

  • Immediate onset: Tissue damage occurs instantly upon contact with the caustic agent, not over days 3
  • Coagulation necrosis: Acid burns cause protein denaturation with well-demarcated borders and eschar formation 3
  • Geographic pattern: Lesion shape corresponds precisely to the area of chemical contact, often with splash or drip patterns 3
  • Depth of injury: Burns extend through dermal layers with visible tissue destruction, not superficial epidermal involvement 3
  • Pain characteristics: Immediate severe burning pain at time of exposure, whereas impetigo is typically painless or mildly tender 3

Diagnostic Approach

History Is Critical

  • Temporal progression: Impetigo develops gradually over several days with characteristic stage progression, while chemical burns are acute with immediate symptom onset 1, 3
  • Exposure history: Direct questioning about chemical contact, occupational exposures, or assault is essential for burn diagnosis 3
  • Preceding trauma: Impetigo often follows minor skin breaks, insect bites, or occurs secondary to eczema or herpes lesions 2

Physical Examination Findings

  • Crust appearance: The honey-colored (golden) crust is pathognomonic for impetigo and will not be present in acute chemical burns 1
  • Lesion borders: Impetigo has irregular, spreading borders with satellite lesions, while acid burns have sharp, well-demarcated edges corresponding to contact area 1, 3
  • Surrounding tissue: Impetigo shows mild erythema around lesions; chemical burns show more extensive surrounding inflammation and edema 1, 3

When to Obtain Tissue Diagnosis

  • Biopsy indications: If clinical presentation is atypical or diagnosis remains uncertain after initial assessment, biopsy of the lesion margin should be performed for both histological and microbiological evaluation 3
  • Culture specimens: For suspected impetigo with treatment failure or atypical features, obtain cultures from vesicle fluid, pus, or erosions to confirm bacterial etiology and guide antibiotic selection 1
  • Histopathology differences: Impetigo shows subcorneal pustules with neutrophils and gram-positive cocci, while chemical burns demonstrate coagulation necrosis through dermal layers 3

Common Pitfalls to Avoid

  • Don't rely on surface swabs alone: For burn wounds, surface swabs reflect colonizing flora rather than true pathogens; tissue biopsy is superior for accurate diagnosis 3
  • Consider secondary infection: Chemical burns can become secondarily infected with S. aureus or Streptococcus, potentially mimicking impetigo if the burn history is not elicited 3
  • Bullous impetigo vs. burn blisters: Bullous impetigo has thin-roofed, flaccid bullae that rupture easily leaving minimal raw surface, while burn blisters are tense with underlying tissue destruction 1, 3
  • Ecthyma confusion: Ecthyma (deeper impetigo variant) presents with circular erythematous ulcers with adherent crusts, but these evolve from vesicles over time rather than appearing acutely 1

Algorithmic Approach

  1. Establish timeline: If lesions appeared immediately after known/suspected chemical exposure → consider acid burn; if evolved over 4-6 days through papule-vesicle-pustule-crust stages → impetigo 1, 3

  2. Assess lesion morphology: Honey-colored crusts on erythematous base → impetigo; coagulated necrotic tissue with eschar → chemical burn 1, 3

  3. Evaluate distribution: Multiple scattered lesions on exposed areas with satellite lesions → impetigo; single or few lesions with geometric pattern matching chemical contact → burn 1, 3

  4. If diagnosis uncertain: Obtain tissue biopsy for histopathology and culture to definitively distinguish between infectious and chemical etiology 3

References

Guideline

Impetigo Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.